SEA/RC66/15 - Progress reports on selected regional committee resolutions: national essential drug policy including the rational use of medicines (SEA/RC64/R5)
View StatisticsShow Statistical Information
AbstractResolution SEA/RC64/R5 urged Member States to undertake a national situational analysis to develop a contextualized roadmap for action to promote rational use of medicines. Such analyses were done by the WHO Regional Office for South-East Asia in collaboration with ministries of health in all 11 Member States. A regional consultation on effective management of medicines, held from 23 to 26 April 2013 and attended by all 11 countries, discussed the findings and concluded that: the situational analyses approach was very useful for monitoring and planning; that all areas of medicine management are under-resourced in most countries; and that partner support is generally limited and fragmented. It was recommended that: governments and partners invest in all areas of drug management including drug supply, drug selection and use, drug regulation and drug policy; WHO appoint adequate dedicated personnel at country and regional offices to ensure meaningful collaboration with ministries of health and to ensure better coordinated support from partners; the situational analysis tool used by WHO Regional Office for South-East Asia be adapted and piloted for use by countries, every two years, in monitoring and planning; all recommendations made by the regional consultation on effective management of medicines with regard to drug supply, drug selection and use, drug regulation, and drug policy and coordination are acted upon by Member States and partners; a regular regional consultation is convened by WHO to share information on progress and to plan the way forward. These recommendations may form the basis of a regional strategy to promote rational use of medicines as recommended by resolution SEA/RC64/R5. The High-Level Preparatory (HLP) Meeting held in the Regional Office in New Delhi, India, from 1 to 3 July 2013 reviewed the attached working paper and made the following recommendations: Actions by Member States (1) To implement the recommendations from the April 2013 regional consultation on effective management of medicines within the context of national health plans, capacity and priorities. (2) To conduct situational analysis every two years, subject to country capacity, for planning, monitoring and evaluation purposes. (3) To draft a resolution on effective management of medicines for consideration by the Sixty-sixth Regional Committee. Actions by WHO-SEARO (1) To support countries to implement the recommendations as proposed by the regional consultation on effective management of medicines including adaptation of the situational analysis protocol developed by WHO/SEARO into a tool for use by countries. (2) To strengthen technical support and review resource allocation to ensure the needs of countries are met in the area of medicines. The working paper and the HLP recommendations are submitted to the Sixty-sixth Session of the Regional Committee for its consideration.
World Health Organization, Regional Office for South-East Asia. (2013). SEA/RC66/15 - Progress reports on selected regional committee resolutions: national essential drug policy including the rational use of medicines (SEA/RC64/R5). WHO Regional Office for South-East Asia. http://www.who.int/iris/handle/10665/128292
Gov't Doc #SEA/RC66/15
MetadataShow full item record
Showing items related by title and MeSH subject.
SEA/RC67/20 - Consultative Expert Working Group on Research and Development: Financing and Coordination (SEA/RC65/R3) World Health Organization, Regional Office for South-East Asia (SEA/RC67/20, 2014-07-28)The Sixty-fifth Session of the WHO Regional Committee for South-East Asia held in Yogyakarta, Indonesia, adopted resolution SEA/RC65/R3 that outlined detailed recommendations and action points for Member States and WHO on the follow-up of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG). The Regional Committee resolution provided the basis for the draft resolution during the open-ended meeting of all WHO Member States, held from 26 to 28 November 2012 in Geneva, leading to WHA66.22 in 2013. As ...
SEA/RC67/18 - 2012: Year of intensification of routine immunization in the South-East Asia Region: Framework for increasing and sustaining coverage (SEA/RC64/R3) World Health Organization, Regional Office for South-East Asia (SEA/RC67/18, 2014-07-28)To respond to the challenge of a large number of unimmunized children in the South-East Asia Region, the Sixty-fourth Session of the WHO Regional Committee for South-East Asia in 2011 adopted resolution SEA/RC64/R3 that declared 2012 as the Year of Intensification of Routine Immunization (IRI). All Member States then developed action plans that focused on intensification of efforts to reach and immunize high-risk or hard-to-reach areas and populations. Bangladesh identified 32 out of 74 districts and city corporations as targets for further ...
World Health Organization, Regional Office for South-East Asia (SEA/RC67/15, 2014-07-28)Countries in the South-East Asia Region are vulnerable to different types of hazards such as annual monsoons, flooding, landslides, earthquakes, tsunamis, conflicts and devastating fires. The magnitude of disasters and their effects have a considerable impact on the morbidity and mortality in the Region, where approximately 25% of the world’s population resides. Deaths in Member States of the Region accounted for 37% (426 152 persons) of the global total mortality from natural disasters in 2003–2012. Health action in emergencies is a crucial ...